发表论文:
2023
- Gao WH, He JY, Chen L, Meng XQ, Ma YN, Liu C*, Zhang MZ*, Fan KL*, Pang D-W* and Yan XY*. Deciphering the catalytic mechanism of superior superoxide dismutase activity of carbon dot nanozyme. Nature Communications. 2023, 14: 160. (IF: 17.7). https://doi.org/10.1038/s41467-023-35828-2.
- Ma YN, Zhao JJ, Cheng LL, Li C, Yan XJ, Deng ZC, Zhang YJ, Liang J, Liu C and Zhang MZ*. Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeutics. Carbon. 2023, 204: 526-537. (IF: 11.3). https://doi.org/10.1016/j.carbon.2023.01.006.
- Jia ZZ#, Wei W#, Tu KS, Fang BY*, Zhang MZ*, and Shi LL*. Point-of-care monitoring of dry eye disease using lysozyme in tear based on commercial pregnancy test strips. Sensors and Actuators B-Chemical. 2023, 378: 133179. (IF: 9.22). https://doi.org/10.1016/j.snb.2022.133179
- Cao YM, Cheng K, Yang M, Deng ZC, Ma YN, Yan XJ, Zhang YY, Jia ZZ, Wang J, Tu KS*, Liang J* and Zhang MZ*. Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease. Journal of Nanobiotechnology. 2023, 21: 21. (IF=9.43). https://doi.org/10.1186/s12951-023-01770-0
- Zhang YJ#, Gao WH#, Ma YN, Cheng LL, Zhang L, Liu QG, Chen JY, Zhao YR, Tu KS*, Zhang MZ* and Liu C*. Integrating Pt nanoparticles with carbon nanodots to achieve robust cascade superoxide dismutase-catalase nanozyme for antioxidant therapy. Nano Today. 2023, 49: 101768. (IF=19.0). https://doi.org/10.1016/j.nantod.2023.101768
- Yan XJ,Meng LZ, Zhang XZ, Deng ZC, Gao BW, Zhang YJ, Yang M, Ma Y, Zhang YY, Tu KS, Zhang MZ*, and Xu QR. Reactive Oxygen Species-Responsive Nanocarrier Ameliorates Murine Colitisby Intervening Colonic Innate and Adaptive Immune Responses. Molecular Therapy. 2023, 31(5):1383-1401. (IF=12.9). https://doi.org/10.1016/j.ymthe.2023.02.017
- Zhang YJ#, Zhao JJ#, Zhang LM, Zhao YR, Zhang YY, Cheng LL, Wang D, Liu Cui, Zhang MX*, Fan KL*, and Zhang MZ*. A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage. Nano Today. 2023, 49: 101798. (IF: 19.0) https://doi.org/10.1016/j.nantod.2023.101798
- Geng XD, Du XC, Wang WJ, Zhang CM, Liu XD, Qu YY, Zhao MW, Li WF, Zhang MZ, Tu KS*, and Li YQ*. Confined cascade metabolic reprogramming nanoreactor for targeted alcohol detoxification and alcoholic liver injury management. ACS Nano. 2023, 17(8): 7443–7455. https://pubs.acs.org/doi/10.1021/acsnano.2c12075
- Zhou Y, Yan XJ, Yang M, Ma YN, Zhang YY, Cui ML*, Zhang MZ* and Zhang MX*. Oral delivery of therapeutic andrographolide/carbon monoxide (CO) donor for synergistic treatment of ulcerative colitis by anti-inflammation and pro-resolution. ACS Applied Materials & Interfaces. 2023 15, 30, 36061–36075. https://doi.org/10.1021/acsami.3c09342
- Yu H, Zhao HY, Zhang YJ, Hou YM, Li YQ, Zhang YY, Li Cheng, Zhang JJ*, Zhang MZ*, and An Ruifang*. Biomimetic nanoreactors for combinational chemo/chemodynamic therapy of choriocarcinoma through synergistic apoptosis and ferroptosis strategy. Chemical Engineering Journal. 2023, 472: 144690. https://doi.org/10.1016/j.cej.2023.144690
- Zhao YR, Xu JW, Zhang YY, Wu F, Zhao W, Li RQ, Zhang MZ*, Zhang YJ*, and Guo Cheng*. Biomimetic redox-responsive prodrug micelles with diselenide linkage for platinum nanozymes augmented sonodynamic/chemo combined therapy of colon cancer. Chemical Engineering Journal. 2023, 472: 144911. https://doi.org/10.1016/j.cej.2023.144911
- Zhang YY#, Zhang YJ#, Li RQ, Zhao YR, Zhao W, Wu F, Li C*, Hou YZ*, and Zhang MZ*. Immune adjuvant functionalized biomimetic nanocarriers combine sonodynamic therapy for enhanced cancer immunotherapy. Chemical Engineering Journal. 2023, 476: 145685. https://doi.org/10.1016/j.cej.2023.145685
- Ding CG, Wang B, Zheng J, Zhang MZ, Li Y, Shen HH, Guo YC, Zheng BX, Tian PX, Ding XM, and Xue WJ. Neutrophil membrane-inspired nanorobots act as antioxidants ameliorate ischemia reperfusion-induced acute kidney injury. ACS Applied Materials & Interfaces. 2023, 15(34): 40292–40303. https://doi.org/10.1021/acsami.3c08573
- Jia ZZ, Zhang YJ, Zhang CY, Wei XY*, and Zhang MZ*. Biosensing intestinal alkaline phosphatase by pregnancy test strips based on target-triggered CRISPR-Cas12a activity to monitor intestinal inflammation. Analytical Chemistry. 2023, 95(37): 14111–14118. https://pubs.acs.org/doi/10.1021/acs.analchem.3c03099
- 蔡鹏,张明真,高博雯*。植物源细胞外囊泡在炎症性肠病治疗中的应用[J]. 现代生物技术研究, 2023; 1: (1): 6-11.
- Liang YL, Zhang MZ, Zhang YJ *, Zhang MX*. Ultrasound sonosensitizers for tumor sonodynamic therapy and imaging: a new direction with clinical translation. Molecules. 2023, 28(18): 6484. https://doi.org/10.3390/molecules28186484
- Jia ZZ#, Liu YN#, Deng ZC, Zhang MZ*, and Tuo Hang*. Carbon dots with light-responsive oxidase-like activity for colorimetric dopamine detection and catalytic mechanism. Frontiers in Chemistry. 2023, 11: 1288418. https://doi.org/10.3389/fchem.2023.1288418
- Deng ZC, Ma WQ, Gao BW, Zhu YY, Zhang YJ, Zhang MX, Li RQ, and Zhang MZ*. Metal polyphenol network/cerium oxide artificial enzymes therapeutic nanoplatform for MRI/CT imaging-aided intestinal inflammation management. Nano Today. 2023, 53: 102044. https://doi.org/10.1016/j.nantod.2023.102044
- He WF#, Jin J#, Zheng SQ, Zhang H, Gao BW, Zhang MZ*, and He Q*. Plant-derived vesicle-like nanoparticles: clinical application exploration and challenges. International Journal of Nanomedicine. 2023, 18: 5671-5683. https://doi.org/10.2147/IJN.S428647
- Ma YN, Deng ZC, Gao BW, Xu CX, Yan XJ, Yang M, Zhang YJ, Tu KS, Zhao JJ*, Xu QR*, and Zhang MZ*. Macrophage-biomimetic liposomes delivery of carbon dots nanozymes ameliorate ulcerative colitis by modulating inflammation pathways and remodeling the redox microenvironment. Chemical Engineering Journal. 2023, 477: 146796. https://doi.org/10.1016/j.cej.2023.146796
- Geng HG#, Chen JY#, Tu KS, Wu QS, Gao JH, Zhu QW, Zhang Z, Zhang YJ, Huang DS*, Zhang MZ*, and Xu QR*. Carbon dot nanozymes as free radicals scavengers for the management of hepatic ischemia-reperfusion injury by regulating the liver inflammatory network and inhibiting apoptosis. Journal of Nanobiotechnology. 2023.
- Liu H, Zhang YJ, Zhang MZ, Zhou Y, Yu ZX*, and Zhang MX*. Oral administration of platinum nanoparticles with cascade SOD/CAT catalytic activity to alleviate ulcerative colitis. Journal of Founctional Materials. 2023.
- Lu GR#, Jia ZZ#, Zhang MZ*, and Xu CL*. A Ratiometric Fluorescent Sensor Based on Chelation Enhanced Fluorescence of Carbon Dots for Zinc Ion Detection. Molecules. 2023.
- Liu C, Hu J, Chen YM, Fan X, Gao WH, Cheng LL, Luo QY*, and Zhang MZ*. Carbon dots enhanced peroxidase-like activity of platinum nanozyme. Nanoscale. 2023.
- Yan XJ, Gao BW, Deng ZC, Xu CX, Ma YN, Zhang YJ, Zhang BJ*, and Zhang MZ*. Platelet-inspired nanomedicine platform targeting activated neutrophils alleviates ulcerative colitis by cascade SOD/CAT nanozymes-mediated free radicals scavenging and controlled neutrophils swarming. Nano Today. 2023.
- Li SJ, Meng CT, Hao Q, Dai LY, Shi JH, Xu J, Zhou X, Zhao ST, Yang JF, Kang HF, Hou YZ, Zhang MZ, Ma XB, Tan MQ, and Wu Hao*. A multistage-responsive antibody-delivery strategy to improve immunotherapy for NSCLC brain metastasis by ultrasensitive releasing and tumor-anchoring. Advanced Functional Materials. 2023.
2022
- Yang M, Yang CH, Zhang YJ, Yan XJ, Ma YN, Zhang YY, Cao YM, Xu QR*, Tu KS* and Zhang MZ*. Orally pH-activated "nano-bomb" carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis. Biomaterials Science. 2022, 10(4):1053-1067. (IF=7.59)
- Ma YN, Gao WH, Zhang YJ, Yang M, Yang XJ, Zhang YY, Li GY, Liu C*, Xu CL* and Zhang MZ*. Biomimetic MOF nanoparticles delivery of C-dot nanozyme and CRISPR/Cas9 system for sitespecific treatment of ulcerative colitis. ACS Applied Materials & Interfaces. 2022, 14(5), 6358−6369. (IF=10.38)
- Gong LY, Zhang YJ, Zhang YL, Tu KS, Jiao LY, Xu QR, Zhang MZ*and Han SX*. All-in-one biomimetic banoplatform based on hollow polydopamine nanoparticles for synergistically enhanced radiotherapy of colon cancer. Small. 2022, e2107656. (IF=15.15)
- Yan XJ, Yang CH, Yang M, Ma YN, Zhang YY, Zhang YJ, Liu C, Xu QR*, Tu KS* and Zhang MZ*. All-in-one theranostic nano-platform based on polymer nanoparticles for BRET/FRET-initiated bioluminescence imaging and synergistically anti-inflammatory therapy for ulcerative colitis. Journal of Nanobiotechnology. 2022, 20(1): 99. (IF=10.435)
- Liu C#, Yan XJ#, Zhang YJ#, Yang M, Ma YN, Zhang YY, Xu QR*, Tu KS* and Zhang MZ*. Turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for treatment of ulcerative colitis. Journal of Nanobiotechnology. 2022, 20(1):206. (IF=10.435)
- Wei W, Zhang YJ, Li RQ, Cao YM, Yan XJ, Ma YN, Zhang YY, Yang M* and Zhang MZ*. Oral delivery of pterostilbene by L-Arginine-mediated “nano-bomb” carrier for the treatment of ulcerative colitis. International Journal of Nanomedicine. 2022, 17, 603-616. (IF=7.03)
- Xu JW#*, Yan XJ#, Zhang Y, Tu KS, Shen W, Tian ZQ, Zhao W* and Zhang MZ. Tunable paclitaxel release carrier using diselenide-disulfide balance as regulator. Journal of Industrial and Engineering Chemistry. 2022, 109, 359-371. (IF: 6.76)
- Zhang MX, Lu N, Li Q, Cui ML*, and Zhang MZ*. Editorial: drugs delivery system based on nanoparticles for inflammation and cancer therapy. Front. Mol. Biosci. 2022, 9: 938348. (IF=6.11)
- Fang BY*, Jia ZZ, Liu C, Tu KS, Zhang MZ, Zhang L*. A versatile CRISPR Cas12a-based point-of-care biosensor enabling convenient glucometer readout for ultrasensitive detection of pathogen nucleic acids. Talanta. 2022, 249:123657. (IF: 6.56)
- Zhang YJ, Zhao YR, Zhang YY, Liu QG, Zhang MZ*, and Tu KS*. The crosstalk between sonodynamic therapy and autophagy in cancer. Frontiers in Pharmacology. 2022, 13: 961725. (IF: 5.988)
- Du CX#, Zhang MZ#, Zhou HT#, Wang WJ, Zhang CM, Qu YY, Li WF*, Liu XD, Zhao MW, Tu KS*, and Li YQ*. Decoy nanozymes enable multi-target blockade of pro-inflammatory cascades to reverse bacterial sepsis. Research. 2022, 9767643. (IF: 11.05)
- Liu C, Hu J, Wei XY, Gao WH, Cheng LL, Pan GT, Luo QY*, Yin GZ*, and Zhang MZ. Carbon Nanodots-stabilized platinum nanoparticles with high peroxidase-like activity for versatile applications. Chemical Communications. 2022. (IF: 6.06) (Under review).
- Liu C, Wei XX, Zhang MZ, Hildebrandt N, Luo QY* and Jin ZW*. Nucleic acid hybridization enhanced luminescence for rapid and sensitive RNA and DNA based diagnostics. Anal Chem. 2022. (IF: 8.0).
- Therapeutic Albumin Nanoparticles Hitchhike Activated Neutrophil Across Vascular Barrier for Subcutaneous and Orthotopic Colon Cancer Therapy (In submission)
2021
- Gong LY, Zhang YJ, Liu CC, Zhang MZ* and Han SX*. Application of Radiosensitizers in Cancer Radiotherapy. International Journal of Nanomedicine. 2021; 16: 1083-1102. (IF=6.4) ( Highly cited)
- 颜湘冀,张玉洁,张明真*。中性粒细胞在溃疡性结肠炎中的作用机制及靶向治疗策略[J]. 右江医学, 2021; 49(2): 87-91
- Jia ZZ, Tu KS, Xu QR, Gao WH, Liu C, Fang BY* and Zhang MZ*. A novel disease-associated nucleic acid sensing platform based on split DNA-scaffolded sliver nanocluster. Analytica Chimica Acta. 2021. (IF=6.558)
- Wang XY#, Zhang MZ#, Woloshun R, Yu Y, Lee J, Flores S, Merlin D and Collins J. Oral Administration of Ginger-Derived Lipid Nanoparticles and Dmt1 siRNA potentiates the Effect of Dietary Iron Restriction and Mitigates Pre-Existing Iron Overload in Hamp KO Mice. Nutrients. 2021, 13(5), 1686. (IF=5.717)
- Ma YN, Qu XL, Liu C, Xu QR* and Tu KS*. Metal-organic frameworks and their composites towards bio-medical applications. Front. Mol. Biosci. 2021, 8: 805228. (IF=5.25)
2020
- An J, Hu YG, Chang K, Li C, Hou XL, Wang GL, Zhang XS, Liu B, Zhao YD* and Zhang MZ*. ROS-Augmented and Tumor-Microenvironment Responsive Biodegradable Nanoplatform for Enhancing Chemo-Sonodynamic Therapy. Biomaterials. 2020; 234: 119761. (IF=10.3)
- Fang BY*, Guo P, Yang M, Ma YN, Yan XJ, Jia ZZ, Gao WH, Ahmad S, Xu CL, Liu C and Zhang MZ*. A Novel Fluorescent Enhancing Platform Based on DNA-scaffolded Silver Nanoclusters for Potential Inflammatory Bowel Disease-associated MicroRNA Detection. Talanta. 2020; 218: 121122. (IF=5.3)
- Yang CH, Zhang MZ, Lama S, Wang LX and Merlin D. Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis. Journal of Controlled Release. 2020; 323: 293-310. (IF=7.877)
- Yang CH, Zhang MZ, Sung J, Wang LX, Jung Y and Merlin D. Isolation and Characterization of Exosomes from Mouse Feces. Bio-protocol. 2020; 10(8): e3584.
- Shi Q, Cheng YH, Dong XM, Zhang M, Pei C and Zhang MZ*. Effects of rhaponticin on retinal oxidative stress and inflammation in diabetes through NRF2/HO-1/NF-kB signaling. Journal of Biochemical and Molecular Toxicology. 2020; e22568. (IF=3.606)
- Yang M, Zhang YJ, Ma YN, Yan XJ, Gong LY, Zhang MZ* and Zhang BJ*. Nanoparticle-based therapeutics of inflammatory bowel diseases: the current state and prospects. Journal of Bio-X Research (2020) 3:193–209.
- Liu C*, Zhang F, Hu J and Zhang MZ. A mini review on pH-sensitive photoluminescence in carbon nanodots. Frontiers in Chemistry.
2019
- Zhang MZ*, Yang CH, Yan XJ, Sung JK, Garg P and Merlin D. Highly Biocompatible Functionalized Layer-by-Layer Ginger Lipid Nano Vectors Targeting P-Selectin for Delivery of Doxorubicin to Treat Colon Cancer. Advanced Therapeutics. 2019; 1900129. (Wiley new journal)
- Yang M, Zhang F, Yang C, Wang L, Sung J, Garg P, Zhang MZ* and Merlin, D. Oral targeted delivery by nanoparticles enhances efficacy of an Hsp90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated cancer. Journal of Crohn's and Colitis. 2019. (IF=7.827)
- Wang X, Zhang MZ, Flores SR, Woloshun RR, Yang C, Yin L, Xiang P, Xu X, Garrick MD, Vidyasagar S, Merlin D and Collins JF*. Oral Gavage of Ginger Nanoparticle-Derived Lipid Vectors Carrying Dmt1 siRNA Blunts Iron Loading in Murine Hereditary Hemochromatosis. Molecular Therapy. 2019; 27(3):493-506. (IF=8.402)
- Li C, Yang XQ, Zhang MZ, Song YY, Cheng K, An J, Zhang XS, Xuan Y, Liu B, Zhao YD. In vivo Imaging-Guided Nanoplatform for Tumor Targeting Delivery and Combined Chemo-, Gene-and Photothermal Therapy. Theranostics. 2018; 8(20):5662. (IF=8.063)
- Zhang MZ*, Xu CL, Wen LQ, Han MK, Xiao B, Zhou J and Merlin D. A hyaluronidase responsive nanoparticle-based drug delivery system for targeting colon cancer cells. Cancer Research. 2016; 76(24), 7208-7218. (IF=8.378)
- Zhang MZ*, Viennois E, Prasad M, Zhang YC, Wang LX, Zhang Z and Merlin D. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016; 101:321-340. (IF=10.273)
- Zhang MZ, Yu Y, Yu RN, Wan M, Zhang RY and Zhao YD*. Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide. Small. 2013; 9:4183-4193. (IF=10.856)
- Zhang MZ*, Xiao B, Wang H, Han MK, Zhang Z, Viennois E and Merlin D. Edible ginger-derived nano-lipids loaded with doxorubicin as a novel drug-delivery approach for colon cancer therapy. Molecular Therapy. 2016; 24(10):1783-96. (IF=8.402)
- Zhang MZ*, Xu CL, Liu DD, Han MK, Wang LX and Merlin D. Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis. Journal of Crohn’s and Colitis. 2018; 12(2): 217-229. (IF=7.827)
- Zhang MZ*, Viennois E, Xu CL and Merlin D. Plant derived edible nanoparticles as a new therapeutic approach against diseases. Tissue Barriers. 2016; e1134415.
- Zhang MZ*, Collins JF and Merlin D. Do Ginger-derived nanoparticles present an attractive treatment strategy for inflammatory bowel disease? Nanomedicine. 2016; 3035-3037. (IF=4.717)
- Zhang MZ*, Wang XY, Han MK, Collins JF and Merlin D. Oral administration of ginger-derived nano-lipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis. Nanomedicine. 2017; 12(16), 1927-1943. (IF=4.717)
- Zhang MZ, Yu RN, Chen J, Ma ZY and Zhao YD*. Targeted quantum dots fluorescence probes functionalized with aptamer and peptide for transferrin receptor on tumor cells. Nanotechnology. 2012; 23:485104. (IF=3.399)
- Zhang MZ, Li C, Fang BY, Yao MH, Ren QQ, Zhang L and Zhao YD*. High transfection efficiency of quantum dot-antisense oligonucleotide nanoparticles in cancer cells through dual-receptor synergistic targeting. Nanotechnology. 2014; 25:255102. (IF=3.399)
- Zhang MZ* and Merlin D. Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis. Inflammatory Bowel Diseases. 2018; 24(7):1401-1415. (IF=4.005)